Nestegg Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$294K Sell
12,225
-557
-4% -$13.8K 0.19% 51
2026
Q2
$322K Buy
12,782
+577
+5% +$14.5K 0.23% 40
2026
Q1
$308K Buy
12,205
+76
+0.6% +$1.94K 0.27% 38
2025
Q4
$310K Buy
12,129
+152
+1% +$3.89K 0.26% 42
2025
Q3
$307K Buy
+11,977
New +$304K 0.27% 38

Other funds holding IBDX

Nestegg Advisors's IBDX Position: Q3 2026 in Review

Nestegg Advisors reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 4.4% in Q3 2026, selling an estimated $13.8K and leaving 12,225 shares worth $294K. The position accounts for 0.19% of the portfolio, ranked #51.

Nestegg Advisors first reported a position in IBDX in Q3 2025 and has held it in 5 quarters since. The position peaked at $322K in Q2 2026. 101 funds tracked by Wall St. Rank hold IBDX as of Q3 2026.

  • Nestegg Advisors held 12,225 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $294K as of Q3 2026.
  • Nestegg Advisors sold 557 iShares iBonds Dec 2032 Term Corporate ETF shares in Q3 2026, an estimated $13.8K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.19% of Nestegg Advisors's portfolio in Q3 2026, its #51 holding.
  • Nestegg Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and has held it in 5 quarters since.
  • Nestegg Advisors's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $322K in Q2 2026.
  • 101 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q3 2026.

Based on Nestegg Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.